MedAvail Announces Continued Expansion of Its Technology Agreement With a North Texas Health System

Rhea-AI Summary

MedAvail Holdings, Inc. (Nasdaq: MDVL), a tech-enabled retail pharmacy, has expanded its technology agreement with a North Texas health system. MedAvail deployed its MedCenter technology at 16 urgent and emergency care sites, allowing patients to consult with pharmacists and fill prescriptions on-site, streamlining access to medications. This initiative aims to enhance medication adherence and patient satisfaction, showcasing MedAvail's adaptability in different healthcare environments. The company's solutions can be branded by enterprise customers, aligning with the company's mission to improve healthcare delivery.

Positive

• Expansion of technology agreement with a health system in North Texas.
• Deployment of MedCenter technology at 16 care sites enhances patient access to medications.
• Supports medication adherence and patient satisfaction.

Negative

• None.

MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, today announced that a health system in North Texas has expanded its technology agreement with MedAvail, and has deployed MedAvail’s MedCenter technology at 16 emergency and urgent care sites in Texas.

Patients visiting these urgent and emergency care sites are able to consult virtually with a system pharmacist and fill their prescriptions at the point of care through the MedCenter, eliminating the need to make a separate trip to a pharmacy. Through MedAvail’s Pharmacy Technology segment, the company is able to enhance pharmacy services offered by healthcare providers and retail chains. Enterprise customers can purchase MedAvail’s technology in order to provide these solutions under their own brands.

“We are proud to offer our software and MedCenter technology to large healthcare systems focused on medication adherence and patient satisfaction,” said Dave Rawlins, Chief Commercial Officer at MedAvail. “Quick and convenient access to care is even more critical now than ever. MedAvail’s innovative pharmacy technology is adaptable to a number of different environments, enabling our partners to improve ease of medication access without compromising safety.”

About MedAvail

MedAvail (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005777/en/

FAQ

What is the recent announcement by MedAvail (MDVL) regarding its technology agreement?

MedAvail announced the expansion of a technology agreement with a North Texas health system, deploying its MedCenter technology at 16 emergency and urgent care sites.

How does the MedCenter technology benefit patients at urgent care sites?

The MedCenter technology allows patients to consult with pharmacists virtually and fill prescriptions on-site, eliminating the need for a separate pharmacy trip.

What are the goals of MedAvail's technology in healthcare?

MedAvail aims to enhance medication adherence and patient satisfaction through its innovative pharmacy technology.

How can enterprise customers utilize MedAvail's technology?

Enterprise customers can purchase MedAvail's technology and offer these pharmacy solutions under their own brands.

What type of services does MedAvail provide through its MedCenter?

MedAvail provides in-clinic pharmacy services through its MedCenter, including robotic dispensing and home delivery operations.